nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of EphB2 in the basolateral amygdala promotes stress vulnerability of mice by increasing NMDA-dependent synaptic function
|
Zhang, Jie-Ting |
|
|
167 |
C |
p. |
artikel |
2 |
Adjunctive effect of the serotonin 5-HT2C receptor agonist lorcaserin on opioid-induced antinociception in mice
|
Sierra, Salvador |
|
|
167 |
C |
p. |
artikel |
3 |
A novel biscoumarin compound ameliorates cerebral ischemia reperfusion-induced mitochondrial oxidative injury via Nrf2/Keap1/ARE signaling
|
Wang, Jun |
|
|
167 |
C |
p. |
artikel |
4 |
A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders
|
Robinson, Stacey L. |
|
|
167 |
C |
p. |
artikel |
5 |
Biomarkers for epileptogenesis and its treatment
|
Engel Jr., Jerome |
|
|
167 |
C |
p. |
artikel |
6 |
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
|
Galaj, Ewa |
|
|
167 |
C |
p. |
artikel |
7 |
Chronic alcohol disrupts hypothalamic responses to stress by modifying CRF and NMDA receptor function
|
Marty, Vincent N. |
|
|
167 |
C |
p. |
artikel |
8 |
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
|
Halberstadt, Adam L. |
|
|
167 |
C |
p. |
artikel |
9 |
Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects
|
Ohmura, Yu |
|
|
167 |
C |
p. |
artikel |
10 |
Disease-modifying strategies in primary tauopathies
|
Rösler, Thomas W. |
|
|
167 |
C |
p. |
artikel |
11 |
Disease-modifying therapies in amyotrophic lateral sclerosis
|
Chiò, Adriano |
|
|
167 |
C |
p. |
artikel |
12 |
Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum
|
Chitre, Neha Milind |
|
|
167 |
C |
p. |
artikel |
13 |
Editorial Board
|
|
|
|
167 |
C |
p. |
artikel |
14 |
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
|
Hirsch, Mauro Mozael |
|
|
167 |
C |
p. |
artikel |
15 |
Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies
|
Boison, Detlev |
|
|
167 |
C |
p. |
artikel |
16 |
Female and male rats readily consume and prefer oxycodone to water in a chronic, continuous access, two-bottle oral voluntary paradigm
|
Zanni, Giulia |
|
|
167 |
C |
p. |
artikel |
17 |
Inflammation and reactive oxygen species as disease modifiers in epilepsy
|
Terrone, Gaetano |
|
|
167 |
C |
p. |
artikel |
18 |
Kappa opioid receptors in the bed nucleus of the stria terminalis regulate binge-like alcohol consumption in male and female mice
|
Haun, Harold L. |
|
|
167 |
C |
p. |
artikel |
19 |
KCC2 antagonism and gabaergic synchronization in the entorhinal cortex in the absence of ionotropic glutamatergic receptor signalling
|
Chen, Li-Yuan |
|
|
167 |
C |
p. |
artikel |
20 |
Learned avoidance requires VTA KOR-mediated reductions in dopamine
|
Robble, Mykel A. |
|
|
167 |
C |
p. |
artikel |
21 |
Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies
|
Ibhazehiebo, Kingsley |
|
|
167 |
C |
p. |
artikel |
22 |
Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference
|
Collins, Devon |
|
|
167 |
C |
p. |
artikel |
23 |
Neurotensin in reward processes
|
Torruella-Suárez, María Luisa |
|
|
167 |
C |
p. |
artikel |
24 |
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model
|
Kim, Siwon |
|
|
167 |
C |
p. |
artikel |
25 |
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder
|
Fuchs, Claudia |
|
|
167 |
C |
p. |
artikel |
26 |
Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies
|
Lewis, Alan S. |
|
|
167 |
C |
p. |
artikel |
27 |
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
|
Pisanò, Clarissa A. |
|
|
167 |
C |
p. |
artikel |
28 |
Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice
|
Zakariassen, Hannah Louise |
|
|
167 |
C |
p. |
artikel |
29 |
Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis
|
Zhang, Cai |
|
|
167 |
C |
p. |
artikel |
30 |
Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy
|
Lin, Thiri W. |
|
|
167 |
C |
p. |
artikel |
31 |
The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments
|
Löscher, Wolfgang |
|
|
167 |
C |
p. |
artikel |
32 |
The hypocretin (orexin) system: from a neural circuitry perspective
|
Li, Shi-Bin |
|
|
167 |
C |
p. |
artikel |
33 |
The path from scientific discovery to cures for epilepsy
|
Carvill, Gemma L. |
|
|
167 |
C |
p. |
artikel |
34 |
The role of prolactin in co-ordinating fertility and metabolic adaptations during reproduction
|
Ladyman, Sharon R. |
|
|
167 |
C |
p. |
artikel |
35 |
The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets
|
Fisher, Ria |
|
|
167 |
C |
p. |
artikel |
36 |
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
|
Barker-Haliski, Melissa |
|
|
167 |
C |
p. |
artikel |